CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. - Wikidata - awgldk - TriplyDB

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

http://www.wikidata.org/entity/Q43940294

about

Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management Proteomic approaches and identification of novel therapeutic targets for alcoholism Diagnosis of alcoholic liver disease.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Naltrexone long-acting formulation in the treatment of alcohol dependence.Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trial.Apo-AII is an elevated biomarker of chronic non-human primate ethanol self-administration.Diagnostic values of surface-enhanced laser desorption/ionization technology for screening of habitual drinkers.Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man.Elevated serum gamma-glutamyltransferase is associated with an increased risk of oesophageal carcinoma in a cohort of 8,388,256 Korean subjects.Estimating driver risk using alcohol biomarkers, interlock blood alcohol concentration tests and psychometric assessments: initial descriptives.How accurate are blood (or breath) tests for identifying self-reported heavy drinking among people with alcohol dependence?Circulating cytokines as biomarkers of alcohol abuse and alcoholism Classification of alcohol abuse by plasma protein biomarkers Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders Motivational interviewing with primary care populations: a systematic review and meta-analysis.Diagnostic performance of ethyl glucuronide in hair for the investigation of alcohol drinking behavior: a comparison with traditional biomarkers.Heavy alcohol use in lung donors increases the risk for primary graft dysfunction The effect of malnutrition on protein glycosylation in children The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community.Plasma proteomic alterations in non-human primates and humans after chronic alcohol self-administration.Validation of the Bayesian Alcoholism Test compared to single biomarkers in detecting harmful drinking.Operating characteristics of carbohydrate-deficient transferrin (CDT) for identifying unhealthy alcohol use in adults with HIV infection Traditional markers of excessive alcohol use.Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption.Use of biomarkers for alcohol use disorders in clinical practice.Efficacy of brief interventions for hazardous drinkers in primary care: systematic review and meta-analyses.Carbohydrate-deficient transferrin (CDT)--a biomarker for long-term alcohol consumption.A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.Emerging biomarkers: new directions and clinical applications.Rhesus monkey model of liver disease reflecting clinical disease progression and hepatic gene expression analysis.The biometric measurement of alcohol consumption.Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis.Liver aminotransferases are elevated with rhabdomyolysis in the absence of significant liver injury Liver Transplantation for Alcohol-Related Liver Disease Ethylglucuronide as a biomarker for ethanol detection.KASL clinical practice guidelines: management of alcoholic liver disease A proteomic workflow for discovery of serum carrier protein-bound biomarker candidates of alcohol abuse using LC-MS/MS Long-term survival after liver transplantation for alcoholic liver disease.

P2860

Q24632593-B4F14E73-36E3-4FE0-A007-9DCCAF395CBC Q24649618-ADFCF872-5FB1-446A-9A26-40DA4A0CF735 Q27023085-B0C4B192-06F3-4319-8E0B-1D60D1616355 Q30431186-C35667C8-1EC4-40C0-9C26-5B7D7059ED49 Q30440516-ABA045EA-A4C1-4582-9004-5B644E8C8106 Q30441807-8851CF58-E014-4A85-A00F-4B79AAA6BB05 Q30851487-E43C2C98-1FDA-48B8-AAA6-36FF17C5E0E3 Q33238373-21A87455-3497-4EC9-A483-5564234B06F8 Q33276236-102B52F9-36C4-4E5E-96F9-F52E772BEA8F Q33618803-6F8D12C8-2E22-4046-83FE-878D8C097AC3 Q33643177-617A5BF9-5C98-4226-AF69-DB9705B94D1F Q33671773-01EBA3F9-675B-43D3-9C78-DB70DC23AF29 Q33767799-C482C5EF-F18D-43CF-AF14-A9EF989C8C66 Q33821192-68964635-CF70-47C1-B81B-FCC9082484A5 Q33932437-0563B041-359B-4F68-9A87-1020624BA5F2 Q33976216-0843A0BC-3B2C-49D3-AD39-8BBEA1B1AED7 Q33988006-89C4138F-9AFD-4F1F-9BC3-A795B217A956 Q34215509-0887B274-DE5C-4933-902F-EC726B33A0A4 Q34678921-90D97733-95A3-46A7-9CF6-8BF35ECB8A8A Q34772834-8D2D4B56-E845-41B3-8981-2E6A22BF562F Q34943447-D7BAAEC6-6E91-4C2A-A253-0DA3D61A1F6B Q35024002-1DF8A26F-A09B-4BBB-B546-7F389337CA1D Q35067210-8F972A11-352D-4F17-8BEA-8C095E29098A Q35353517-D765FFAC-F108-49D7-BECF-072CF63C349D Q35675680-35DE150B-8D5A-4A23-8885-708E8CD7CE1F Q35675682-2915508B-3408-441A-830C-6BBF9D4EA39D Q35675693-0ED83E71-8229-49DE-A7E8-747F5CBBF81B Q35752357-E814880C-463E-4A88-8D87-9B3F7156D2AF Q35809820-2D2226AE-7C05-486B-94B4-3AAE0CA6957B Q35886418-5E07741B-5083-4462-9AEC-82D904D0179E Q36071949-8CFDF221-8C2B-4C11-8952-930C770C7EFE Q36128791-6CEB174A-AC4D-4E21-A2FF-F97C094C2137 Q36288415-CD9F18D3-9CF0-459B-B9A2-1321B67ABFE4 Q36432550-07B20745-8614-4689-BB98-BE400A901427 Q36549640-FAE2EF24-B2E8-4B25-9E4D-0BF590E7FB62 Q36886533-F7D19323-C161-49AD-ACCB-935D9A6406BD Q37173203-FCDA8C4F-4BF7-411D-953B-2A6B97542851 Q37229858-93B0EBB7-9A1B-43A3-B940-82F116B5B68A Q37374485-D444CB3D-C87A-4DF1-8F51-7F1773FC6A4A Q37439878-95DEE9AF-3E83-4BAD-97EA-8E3C229B8E91

P2860

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

http://www.wikidata.org/entity/Q43940294

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

@en

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

@nl

type

label

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

@en

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

@nl

prefLabel

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

@en

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

@nl

P1433

Q43940294-E64A6385-A71E-4F7A-815A-3FFD003C1D2A

P1476

Q43940294-A4533753-AA13-4CCB-8C87-1A0E9413179A

P2093

Q43940294-1EBCA893-F553-4D09-99FC-6CABEF188001

Q43940294-57EBF905-FDFF-427D-9C28-FB99EB76616B

Q43940294-85C62FDD-7C67-4FB5-A9D3-86890606A191

Q43940294-E4DE9BE7-AF3C-41B5-B818-75E27861BC8D

Q43940294-E8DEBFC2-F013-496A-921E-48568BD17FC3

P2860

Q43940294-1FB447A5-B69C-497E-8F6D-273518DF6586

Q43940294-5548E5EE-F753-461A-9702-A39EE4BB5690

Q43940294-62DFE608-E656-478E-8713-F810AC796B15

Q43940294-918D5AAB-6857-41FA-9BC0-2A537B85B25B

Q43940294-96447C29-761A-4FF1-8058-0A2F3C7D3FF5

P304

Q43940294-841E0A8F-606E-4D1C-B9B4-DFF8FD933BD3

P31

Q43940294-D80AC46C-1886-47E5-9A52-0B999B53476D

P356

Q43940294-5172A665-DE49-445D-813A-39B865EFCD37

P407

Q43940294-A91D8E24-0712-4499-BF48-6DDBFFD98AFE

P433

Q43940294-1BD47BFF-0C92-4BEE-813D-5EFB484D70DD

P478

Q43940294-645882D6-DC1C-4281-8019-71528CEA0A51

P50

Q43940294-497CC30B-7B90-4572-AA25-8BFF8E38BB57

Q43940294-C1CCFCCC-3EE4-455B-B4F3-815EE01AC6AF

P577

Q43940294-A88FC26F-09FE-4B28-9DF0-15EA075A1149

P5875

Q43940294-304C2CA4-D797-4759-A75F-F69950534875

P698

Q43940294-C0508F41-C94B-424B-95D4-A4B7C96CDC17

P921

Q43940294-3BCC9E1C-FB83-48E8-B64D-080423EE5FD5

Q43940294-9B5431C2-B51C-4572-B87F-EDCE30F914B7

Q43940294-BC2B14F5-EBF3-4E92-B0D9-ECA568F0D85B

P356

J.1530-0277.2002.TB02542.X

P1433

Alcoholism: Clinical and Experimental Research

P1476

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project.

@en

P2093

Boris Tabakoff

http://www.w3.org/2001/XMLSchema#string

John B Saunders

http://www.w3.org/2001/XMLSchema#string

John B Whitfield

http://www.w3.org/2001/XMLSchema#string

Katherine M Conigrave

http://www.w3.org/2001/XMLSchema#string

WHO/ISBRA Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

The health benefits of moderate alcohol consumption: a review of the literature.

The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample.

Treatment of alcohol dependence: experiences of using biological markers in monitoring and prevention of relapse.

Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. WHO/ISBRA Collaborative Study Investigators. International Society for Biomedical Research on Alcoholism.

Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee.

P304

332-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1530-0277.2002.TB02542.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Louisa Degenhardt

Anders Helander

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11440882

http://www.w3.org/2001/XMLSchema#string

P698

11923585

http://www.w3.org/2001/XMLSchema#string

P921

alcohol consumption

Alþjóðaheilbrigðismálastofnunin